Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,255 USD | -0,40% | +4,58% | +19,52% |
Omzet 2024 * | 7,78 mln. 7,22 mln. | Omzet 2025 * | 8,72 mln. 8,09 mln. | Marktkapitalisatie | 89,37 mln. 82,9 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -73 mln. -67,72 mln. | Nettowinst (verlies) 2025 * | -100 mln. -92,77 mln. | EV/omzet 2024 * | 2,33 x |
Nettoliquiditeiten 2024 * | 71,24 mln. 66,09 mln. | Nettoliquiditeiten 2025 * | 157 mln. 146 mln. | EV/omzet 2025 * | -7,8 x |
K/w-verhouding 2024 * |
-1,29
x | K/w-verhouding 2025 * |
-1,06
x | Werknemers | 89 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,23% |
Recentste transcriptie over Aclaris Therapeutics, Inc.
1 dag | +6,78% | ||
1 week | +5,88% | ||
Lopende maand | +5,88% | ||
1 maand | +5,00% | ||
3 maanden | +18,87% | ||
6 maanden | -81,08% | ||
Lopend jaar | +20,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 01-07-12 |
Kevin Balthaser
DFI | Director of Finance/CFO | - | 01-01-17 |
Joseph Monahan
CTO | Chief Tech/Sci/R&D Officer | 68 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 09-08-17 |
Maxine Gowen
BRD | Director/Board Member | 66 | 02-07-19 |
Andrew Powell
BRD | Director/Board Member | 66 | 25-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.08% | 0 M€ | 0,00% | - | |
0.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,25 | -0,79% | 305 355 |
27-03-24 | 1,26 | +6,78% | 1 286 232 |
26-03-24 | 1,18 | +1,72% | 716 343 |
25-03-24 | 1,16 | +0,87% | 586 693 |
22-03-24 | 1,15 | -4,17% | 548 773 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,00% | 89,37 mln. | |
+9,16% | 45,97 mld. | |
+53,63% | 43,93 mld. | |
+11,20% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,40% | 27,18 mld. | |
-19,34% | 19,44 mld. | |
+13,95% | 13,83 mld. | |
+31,56% | 12,4 mld. | |
+10,63% | 11,45 mld. |